Biological coating with platelet-rich plasma and adipose tissue-derived microvascular fragments improves the vascularization, biocompatibility and tissue incorporation of porous polyethylene
Source abstract
Abstract
Porous polyethylene (pPE) is a commonly used biomaterial in craniofacial reconstructive surgery. However, implant failure due to insufficient vascularization represents a major issue. To overcome this problem, we herein introduce an effective strategy to improve the vascularization and incorporation of pPE. Adipose tissue-derived microvascular fragments (MVF) from transgenic green fluorescent protein (GFP)+ mice were suspended in platelet-rich plasma (PRP) for the coating of pPE. PRP/MVF-coated pPE as well as PRP-coated and uncoated controls were subsequently implanted into the dorsal skinfold chamber and the flanks of GFP- wild-type mice to analyze their in vivo performance throughout 2, 4 and 8 weeks by means of intravital fluorescence microscopy, histology and immunohistochemistry. The GFP+/GFP- cross-over design allowed the identification of GFP+ MVF within the implants. Shortly after implantation, they rapidly reassembled into new blood-perfused microvascular networks, resulting in a significantly accelerated vascularization of PRP/MVF-coated pPE when compared to both controls. The overall numbers of rolling and adherent leukocytes within the microcirculation as well as macrophages, multi-nucleated giant cells and mast cells around the implants did not differ between the three groups. However, in contrast to uncoated controls, PRP/MVF-coated and PRP-coated pPE promoted pro-angiogenic M2 macrophage polarization at the implantation site. These findings demonstrate that PRP/MVF-coating represents a highly effective strategy to enhance the vascularization, biocompatibility and tissue incorporation of pPE. STATEMENT OF SIGNIFICANCE: The clinical in vivo performance of implanted biomaterials is crucially dependent on their adequate incorporation into the body. To achieve this, we herein introduce an effective biological coating strategy. Our results demonstrate that coating with PRP and MVF accelerates and enhances the vascularization, biocompatibility and tissue incorporation of porous polyethylene. Because this type of biological coating is easily applicable on any type of biomaterial, our approach may rapidly be translated into clinical practice to improve the outcome of various regenerative approaches.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Reconstructive Surgery and Microvascular Techniques · Tissue Engineering and Regenerative Medicine · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Exposure of high-density porous polyethylene (Medpor) used for contour restoration and treatment10.1054/bjom.1998.0038 ↗
2. Porous high-density polyethylene for orbital reconstruction10.1001/archotol.131.5.446 ↗
3. The use of alloplastic materials in rhinoplasty surgery: a meta-analysis10.1097/01.prs.0000299386.73127.a7 ↗
4. Ear reconstruction with porous polyethylene implants
5. Porous high-density polyethylene in facial reconstruction and revision rhinoplasty: a prospective cohort study10.1186/1746-160X-8-17 ↗
6. [Tissue engineering using porous polyethylene implants]10.1007/s00106-012-2667-y ↗
7. A method for visualizing high-density porous polyethylene (medpor, porex) with computed tomographic scanning10.1097/SCS.0b013e3181f6f5fc ↗
8. Facial reconstruction using porous high-density polyethylene (medpor): long-term results10.1007/s00266-012-9911-4 ↗
9. Reconstruction of cranioplasty using medpor porouspolyethylene implant10.1016/j.neuchi.2017.07.001 ↗
10. Ear reconstruction using porous polyethylene implants. Effect of cortisone on edema reduction and healing process10.1007/s00106-010-2226-3 ↗
11. Comparison of vascularization of Medpor and Medpor-plus orbital implants: a prospective, randomized study10.1097/IOP.0b013e318158ec8e ↗
12. Vitalization of porous polyethylene (Medpor®) with chondrocytes promotes early implant vascularization and incorporation into the host tissue10.1089/ten.tea.2011.0340 ↗
13. Clinical and histologic response of subcutaneous expanded polytetrafluoroethylene (Gore-Tex) and porous high-density polyethylene (Medpor) implants to acute and early infection10.1001/archotol.1997.01900030110014 ↗
14. Surface modification by plasma etching impairs early vascularization and tissue incorporation of porous polyethylene (Medpor®) implants10.1002/jbm.b.33528 ↗
15. Vitronectin promotes the vascularization of porous polyethylene biomaterials10.1016/j.actbio.2018.10.004 ↗
16. Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel10.1016/S0168-3659(01)00360-1 ↗
17. Biocompatibility of porous polyethylene implants tissue-engineered by extracellular matrix and VEGF10.1002/jbm.a.32670 ↗
18. Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects10.1371/journal.pone.0116883 ↗
19. Pre-operative in vitro fibroblast coating of porous polyethylene compound grafts - Cell survival in vivo and effects on biocompatibility
20. Large-scale time series microscopy of neovessel growth during angiogenesis10.1007/s10456-015-9461-x ↗
21. Isolation of murine adipose tissue-derived microvascular fragments as vascularization units for tissue engineering
22. Adipose tissue-derived microvascular fragments improve vascularization, lymphangiogenesis, and integration of dermal skin substitutes10.1016/j.jid.2016.08.010 ↗
23. Potentials and limitations of Integra® flowable wound matrix seeded with adipose tissue-derived microvascular fragments10.22203/eCM.v033a20 ↗
24. Enoxaparin does not affect network formation of adipose tissue-derived microvascular fragments10.1111/wrr.12621 ↗
25. Platelet-rich plasma (PRP): what is PRP and what is not PRP?10.1097/00008505-200110000-00002 ↗
26. Short-term cultivation of in situ prevascularized tissue constructs accelerates inosculation of their preformed microvascular networks after implantation into the host tissue10.1089/ten.tea.2010.0329 ↗
27. The dorsal skinfold chamber: window into the dynamic interaction of biomaterials with their surrounding host tissue10.22203/eCM.v022a12 ↗
28. Off-line analysis of red blood cell velocity in renal arterioles10.1159/000025710 ↗
29. Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility and vascularization10.1002/jbm.b.30755 ↗
30. Angiogenic and inflammatory host response to surgical meshes of different mesh architecture and polymer composition10.1002/jbm.b.31423 ↗
31. Simultaneous localization of proteoglycan by light and electron microscopy using toluidine blue O – a study of epiphyseal cartilage10.1177/24.5.132503 ↗
32. Angiogenic and inflammatory host response to surgical meshes of different mesh architecture and polymer composition10.1002/jbm.b.31423 ↗
33. Regulation of leukocyte recruitment by local wall shear rate and leukocyte delivery10.1080/10739680490266199 ↗
34. Porous polyethylene (Medpor) orbital implant. Prospective study of 75 primary implantations
35. The smooth surface tunnel porous polyethylene enucleation implant10.3928/1542-8877-20040901-03 ↗
36. Comparative study of the safety and efficacy of the AHMED glaucoma valve model M4 (high density porous polyethylene) and the model S2 (polypropylene) in patients with neovascular glaucoma10.1016/j.oftal.2016.02.009 ↗
37. High density porous polyethylene material (Medpor) as an unwrapped orbital implant10.1631/jzus.2006.B0679 ↗
38. Combined fascial flap and expanded skin flap for enveloping MEDPOR framework in microtia reconstruction10.1007/s00266-008-9249-0 ↗
39. Prevascularization of collagen-glycosaminoglycan scaffolds: stromal vascular fraction versus adipose tissue-derived microvascular fragments10.1186/s13036-018-0118-3 ↗
40. Autologous platelet-rich plasma/thrombin gel combined with split-thickness skin graft to manage postinfectious skin defects: a randomized controlled study10.1097/01.ASW.0000524399.74460.87 ↗
41. Effect of autologous platelet-rich plasma gel on skin flap survival10.12659/MSM.913115 ↗
42. Seeding density is a crucial determinant for the in vivo vascularisation capacity of adipose tissue-derived microvascular fragments10.22203/eCM.v034a04 ↗
43. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation10.2337/diabetes.50.9.2080 ↗
44. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo10.1007/s10456-013-9381-6 ↗
45. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential10.1093/bmb/ldt031 ↗
46. Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice10.1016/j.biomaterials.2006.05.033 ↗
47. In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering10.1016/j.actbio.2009.02.006 ↗
48. Animal models in surgical lymphedema research – a systematic review10.1016/j.jss.2015.07.005 ↗
49. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha10.1038/329630a0 ↗
50. Drug delivery strategies to control macrophages for tissue repair and regeneration10.1177/1535370216649444 ↗
51. Effects of Salvia miltiorrhiza polysaccharides on lipopolysaccharide-induced inflammatory factor release in RAW264.7 cells10.1089/jir.2017.0087 ↗
52. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels10.1016/j.biomaterials.2013.09.103 ↗
53. Cytokine, chemokine, and growth factor profile of platelet-rich plasma10.3109/09537104.2016.1143922 ↗
54. Macrophage activation and polarization10.2741/2692 ↗
55. Neovascularization, angiogenesis and nutritive perfusion in wound healing10.1159/000492410 ↗
56. Estrogen stimulates homing of endothelial progenitor cells to endometriotic lesions10.1016/j.ajpath.2016.04.004 ↗
57. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
58. Macrophages, foreign body giant cells and their response to implantable biomaterials10.3390/ma8095269 ↗
59. The pathology of the foreign body reaction against biomaterials10.1002/jbm.a.35958 ↗
60. Effects of mast cell modulation on early host response to implanted synthetic meshes10.1007/s10029-010-0680-1 ↗
61. Kinetics of multinucleate giant cell formation and their modification by various agents in foreign body reactions